These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1609472)

  • 1. Myxomatosis vaccine.
    Lawton MP
    Vet Rec; 1992 May; 130(18):407-8. PubMed ID: 1609472
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
    Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
    Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vaccine against myxomatosis and RHD: a step forward for rabbit health.
    Meredith A
    Vet Rec; 2012 Mar; 170(12):307-8. PubMed ID: 22447788
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Administration of vaccine against myxomatosis using live MXT by means of external ear puncture with a special needle].
    Cupera Z; Krupka V; Jiran E
    Vet Med (Praha); 1982; 27(10):617-26. PubMed ID: 6815860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of rabbit myxomatosis in Poland.
    Górski J; Mizak B; Chrobocińska M
    Rev Sci Tech; 1994 Sep; 13(3):869-79. PubMed ID: 7949359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D
    Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival.
    Guitton JS; Devillard S; Guénézan M; Fouchet D; Pontier D; Marchandeau S
    Prev Vet Med; 2008 Apr; 84(1-2):1-10. PubMed ID: 18045714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease.
    Torres JM; Sánchez C; Ramírez MA; Morales M; Bárcena J; Ferrer J; Espuña E; Pagès-Manté A; Sánchez-Vizcaíno JM
    Vaccine; 2001 Aug; 19(31):4536-43. PubMed ID: 11483281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild.
    Ferreira C; Ramírez E; Castro F; Ferreras P; Alves PC; Redpath S; Villafuerte R
    Vaccine; 2009 Nov; 27(50):6998-7002. PubMed ID: 19800438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms.
    Dalton KP; Nicieza I; de Llano D; Gullón J; Inza M; Petralanda M; Arroita Z; Parra F
    Vet Microbiol; 2015 Aug; 178(3-4):208-16. PubMed ID: 26009303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous lesions in pet rabbits following subcutaneous administration of a novel bivalent vaccine against myxomatosis and rabbit haemorrhagic disease.
    Selleri P; Di Girolamo N; Vögtlin A; Fileccia I; Hoop R; Bongiovanni L
    Vet Dermatol; 2014 Dec; 25(6):563-6, e100. PubMed ID: 25227274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral skin diseases of the rabbit.
    Meredith AL
    Vet Clin North Am Exot Anim Pract; 2013 Sep; 16(3):705-14. PubMed ID: 24018033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of low success of blind vaccination campaigns against myxomatosis and rabbit haemorrhagic disease on survival of adult European wild rabbits.
    Rouco C; Moreno S; Santoro S
    Prev Vet Med; 2016 Oct; 133():108-113. PubMed ID: 27663647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of an attenuated strain of infectious myxoma virus obtained by passage in cell cultures (MacKercher and Saito, 1964)].
    Jacotot H; Virat B; Reculard P; Vallée A; Le Bouquin MJ; Boutry JM; Gobert D
    Ann Inst Pasteur (Paris); 1967 Aug; 113(2):221-37. PubMed ID: 6055855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
    Marlier D; Mainil J; Boucraut-Baralon C; Linden A; Vindevogel H
    J Comp Pathol; 2000; 122(2-3):115-22. PubMed ID: 10684680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxomatosis: the virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis.
    Edmonds JW; Nolan IF; Shepherd RC; Gocs A
    J Hyg (Lond); 1975 Jun; 74(3):417-8. PubMed ID: 1056963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxomatosis in wild rabbit: design of control programs in Mediterranean ecosystems.
    García-Bocanegra I; Astorga RJ; Napp S; Casal J; Huerta B; Borge C; Arenas A
    Prev Vet Med; 2010 Jan; 93(1):42-50. PubMed ID: 19818517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection for resistance to myxomatosis in domestic rabbits (Oryctolagus cuniculus).
    Sobey WR
    J Hyg (Lond); 1969 Dec; 67(4):743-54. PubMed ID: 5261215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.